Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB.p Marsh Regulatory News (BPM)

Share Price Information for B.p Marsh (BPM)

Share Price is delayed by 15 minutes
Get Live Data
700.00    0.00 (0.00%)
Bid:
690.00
Ask:
710.00
Spread: 20.00 (2.899%)
Market Cap: £246.67m
BPM Live PriceLast checked at - London Stock Exchange

Intraday B.p Marsh Share Chart

Deferred Consideration Receipt & Special Dividend

16 Apr 2026 07:00

RNS Number : 6400A
B.P. Marsh & Partners PLC
16 April 2026
Β 

16 April 2026

B.P. Marsh & Partners Plc

("B.P. Marsh", "the Company" or "the Group")

Β 

Receipt of Deferred Consideration Following Sale

and

Intention to Declare a Special Dividend

Β 

Further to the announcements made on 25 March 2024 and 16 April 2025, B.P. Marsh & Partners Plc (AIM: BPM), the specialist private equity investor in early-stage financial services businesses, is pleased to confirm that it has received the final tranche of deferred consideration of Β£9.5m from the disposal of its shareholding in Paladin Holdings Limited, the parent company of CBC UK Limited.

Β 

Β· Final tranche of deferred consideration of Β£9.5m

Β· Total proceeds received from sale, including upfront and deferred consideration, of Β£62.7m

Β· Initial investment comprised of Β£3.5k in equity and Β£5.9m of loan funding

Β· Internal Rate of Return of 48.7%

Β 

Use of Proceeds

Β 

Following receipt of Β£9.5m (being the second and final tranche of deferred consideration), the Company announces its intention to return a total of Β£2.0m to shareholders in the Financial Year ending 2028 by way of special dividend, subject to Board approval. Further details regarding the special dividend will be announced in due course.

Β 

The above demonstrates the Company's disciplined capital allocation approach, balancing shareholder returns with maintaining adequate liquidity to support its pipeline of investment opportunities.

Β 

Dividends

Β 

Β· Dividends of Β£10.5m paid, with a final dividend of Β£2.5m proposed, in the Financial Year ending 2027, totalling Β£13.0m

Β 

Β· The intended Β£2.0m special dividend would increase total dividends in the Financial Year ending 2028 to Β£7.0m

Β 

Β· This represents an aggregate of Β£28.0m of dividends paid and/or intended to be paid across the Financial Years ending 2026, 2027 and 2028

Β 

Β· This equates to approximately 8% of the Group's Net Asset Value, based on aggregate dividends of Β£28.0m relative to the Net Asset Value as at 31 July 2025 of Β£349.5m

Β 

The Company remains committed to its established dividend policy, which seeks to deliver sustainable and progressive returns to shareholders over the long term, while retaining sufficient capital to support the growth of the investment portfolio.

Β 

Dividend distributions are considered alongside the Company's capital allocation priorities, including reinvestment into existing and new opportunities and, where appropriate, share buy-backs.

Β 

For further information on B.P. Marsh, its strategy and current portfolio, please contact:Β 

B.P. Marsh & Partners Plc

Daniel Topping / Alice Foulk

Β 

+44 (0)20 7233 3112

Nominated Adviser & Joint Corporate Broker:

Singer Capital Markets Advisory LLP

Charles Leigh-Pemberton / Peter Steel / James Todd

Β 

+44 (0)20 7496 3000

Joint Corporate Broker:

Investec Bank plc

Christopher Baird / David Anderson / Maria Gomez de Olea

Β 

+44 (0)20 7597 5970

Financial PR & Investor Relations:

Tavistock

Simon Hudson / Katie Hopkins / Kuba Stawiski

bpmarsh@tavistock.co.uk

+44 (0)20 7920 3150

Β 

About B.P. Marsh

Β 

B.P. Marsh & Partners Plc (AIM: BPM) is a specialist investor in early stage and small to medium-sized financial services intermediary businesses, with a particular focus on the insurance sector. Bridging the gap to traditional private equity funding rounds, B.P. Marsh takes a typical initial equity stake of up to Β£5m, often complemented by loans, and is able to tailor its investment model to each opportunity. Taking a long-term view of its investments, with an average holding period of around seven years, the Group supplies strategic insight and capital while empowering entrepreneurial management teams to grow their businesses.

Β 

The B.P. Marsh portfolio is diversified by geography and class of business, spanning insurance brokers, underwriting agencies and financial advisers in the UK, Europe, North America and other international markets. For further information, including details of the current portfolio and recent exits, please visit:Β www.bpmarsh.co.uk.

Β 

Forward-looking statements

Β 

This announcement may include statements, beliefs or opinions that are, or may be deemed to be, "forward-looking statements". These forward-looking statements may be identified by the use of forward-looking terminology, including the terms "believes", "estimates", "plans", "projects", "anticipates", "targets", "aims", "continues", "expects", "intends", "hopes", "may", "will", "would", "could" or "should" or, in each case, their negative or other variations or comparable terminology, or by discussions of strategy, plans, objectives, goals, future events or intentions. No representation or warranty is made that any of these statements or forecasts will come to pass or that any forecast results will be achieved. Forward-looking statements may and often do differ materially from actual results. Any forward-looking statements contained in the announcement speak only as of their respective dates, reflect B.P. Marsh's current view with respect to future events and are subject to risks relating to future events and other risks, uncertainties and assumptions relating to B.P. Marsh's business, results of operations, financial position, liquidity, prospects, growth and strategies.

Β 

Except as required by any applicable law or regulation, B.P. Marsh expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained in this announcement or any other forward-looking statements it may make whether as a result of new information, future developments or otherwise.Β 

Β 

- Ends -

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCEASLSFSKKEFA
Date   Source Headline
17th Oct 20237:00 amRNSHalf-Year Results
11th Oct 20234:05 pmRNSNotice of Half Year Results
10th Oct 20237:00 amRNSCompletion of Sale of Kentro Capital Limited
2nd Oct 202312:05 pmRNSTransaction in Own Shares
25th Sep 202310:28 amRNSTransaction in Own Shares
19th Sep 20233:50 pmRNSTransaction in Own Shares
18th Sep 202311:18 amRNSTransaction in Own Shares
18th Sep 20237:00 amRNSTrading Statement
14th Sep 20232:49 pmRNSTransaction in Own Shares
11th Sep 20234:29 pmRNSTransaction in Own Shares
7th Sep 20235:32 pmRNSTransaction in Own Shares
5th Sep 20234:24 pmRNSTransaction in Own Shares
4th Sep 20232:48 pmRNSTransaction in Own Shares
1st Sep 20233:13 pmRNSTransaction in Own Shares
30th Aug 20231:58 pmRNSTransaction in Own Shares
29th Aug 20239:03 amRNSTransaction in Own Shares
24th Aug 202312:06 pmRNSTransaction in Own Shares
22nd Aug 20233:19 pmRNSTransaction in Own Shares
21st Aug 20234:12 pmRNSTransaction in Own Shares
18th Aug 20235:06 pmRNSTransaction in Own Shares
17th Aug 20235:25 pmRNSTransaction in Own Shares
16th Aug 202311:41 amRNSTransaction in Own Shares
15th Aug 202311:54 amRNSTransaction in Own Shares
11th Aug 202312:21 pmRNSTransaction in Own Shares
10th Aug 20239:28 amRNSTransaction in Own Shares
9th Aug 20233:24 pmRNSTransaction in Own Shares
9th Aug 20231:44 pmRNSInvestee Company Update - LEBC
8th Aug 20235:23 pmRNSHolding(s) in Company
7th Aug 20234:25 pmRNSShare Buy-Back Policy
4th Aug 20234:00 pmRNSPDMR and Director Dealings
3rd Aug 20238:58 amRNSTransaction in Own Shares
1st Aug 20235:00 pmRNSTransaction in Own Shares
31st Jul 20232:17 pmRNSTransaction in Own Shares
26th Jul 20234:07 pmRNSResult of AGM
25th Jul 20234:22 pmRNSTransaction in Own Shares
25th Jul 20233:25 pmRNSTransaction in Own Shares
21st Jul 20231:17 pmRNSTransaction in Own Shares
19th Jul 20233:44 pmRNSTransaction in Own Shares
18th Jul 202311:36 amRNSTransaction in Own Shares
11th Jul 20234:02 pmRNSTransaction in Own Shares
10th Jul 20232:41 pmRNSTransaction in Own Shares
30th Jun 202312:05 pmRNSDirector/PDMR Shareholding
30th Jun 20237:00 amRNSNotice of AGM
27th Jun 20233:06 pmRNSTransaction in Own Shares
26th Jun 202311:43 amRNSTransaction in Own Shares
22nd Jun 202310:59 amRNSTransaction in Own Shares
21st Jun 20231:10 pmRNSNew Investment – Pantheon Specialty Limited
21st Jun 202311:53 amRNSTransaction in Own Shares
19th Jun 20231:15 pmRNSTransaction in Own Shares
13th Jun 202312:08 pmRNSDividend payment date correction

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.